Keryx Biopharmaceuticals Announces Participation in a Renal Disease Panel at the JMP Securities Life Sciences Conference on Thursday, June 21st
The JMP Securities Life Sciences Conferenceon Thursday, June 21stat 11:00 a.m. Eastern time: Keryx will be participating in a 50 minute panel discussion titled Renal Disease: Recent Advancements and Future Prospects at The St. Regis New York Hotelin New York City.
A live audio webcast of the panel discussion will be accessible from Keryx’s website at http://investors.keryx.com within the Investor Relations section under “events and presentations.” An archived version of the webcast will be available for at least 15 days following the conclusion of the panel discussion.
KERYX BIOPHARMACEUTICALS CONTACT
Amy SullivanSenior Vice President, Corporate Affairs T: 617.466.3519 email@example.com
Source: Keryx Biopharmaceuticals, Inc.